Healthy financing opportunities.

LDC has invested more than £220m of equity capital to back more than 25 businesses across the healthcare industry over the last 35 years.

The UK healthcare and pharmaceuticals sector is thriving. Fundamental growth drivers, including an ageing population, increasing influence of technology and demand for homecare has created significant opportunity.

Our team has built an enviable track record in backing the growth ambitions of management teams from across the sector, with particular experience in the dynamic pharmaceutical and medical equipment sectors.

Having worked with management teams from Quantum Pharmaceutical, Synexus, Aesica Pharmaceuticals and Prism Medical UK to support their growth plans, LDC remains an active investor in the healthcare sector.

Recent Healthcare Transactions

  • ChargePoint Technology Logo

    ChargePoint Technology

    ChargePoint Technology is a market leader manufacturer and innovator of specialist high containment and sterile transfer valves.
    Type
    Management Buyout
    Deal Size
    Undisclosed
    Entry Date
    10/01/2017
    Exit Date
    -
  • Synexus Logo

    Synexus

    Synexus is the world's largest multi-national company focused on the recruitment and running of clinical trials.
    Type
    Management Buyout
    Deal Size
    £150m to £200m
    Entry Date
    23/02/2015
    Exit Date
    06/06/2016